Vascular PRN

New Pharmaceutical Alternative to Anti-Clotting Medications Offers Benefits, Risks


Tampa, FL -- (SBWIRE) -- 10/16/2014 -- A large number of patients cannot take traditional anti-clotting drugs, such as warfarin, because of the risks of internal bleeding and drug interactions.

Now, a group of Australian researchers has found a proven, surprising alternative: aspirin.  

According to a new study, a daily aspirin offers some protective effect against recurrent blood clots. The University of Sydney published a report showing that a daily aspirin can reduce the risk of recurrent blood clots by 42 percent.

But that reduced risk comes with a price, according to researchers at the Mayo Clinic. They named bleeding problems, stomach ulcers and aspirin-induced asthma as significant concerns for anyone taking aspirin every day.

In addition, the researchers stated that a daily aspirin regimen can be risky because when someone stops taking the aspirin every day, the risk of rebound-effect blood clots increases.

“There is only one proven method of blood clot prophylaxis that does not increase the risk of internal bleeding: external compression therapy,” explained Greg Grambor, president of Vascular PRN. “It is a safer choice, and it is highly effective in preventing blood clots during periods of acute risk, particularly when a person is temporarily confined to bed after surgery. That is one reason so many patients choose medical facilities that offer compression therapy.”

MedPage Today reports that newer anti-clotting medications like Pradaxa are problematic because they do not have reversal agents. If the medication does cause internal bleeding, doctors have fewer ways to control the bleeding in time to save the patient’s life.

About Vascular PRN
Vascular PRN distributes intermittent and sequential compression devices, which offer a proven non-pharmaceutical method for helping to prevent deep vein thrombosis or blood clots in the extremities.

Learn more at